Pentwater Capital Management LP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$180,705,000
+7398.1%
1,050,000
+985.0%
1.84%
+8642.9%
Q3 2015$2,410,000
-64.1%
96,771
-54.4%
0.02%
-41.7%
Q2 2015$6,708,000
+114.9%
212,000
+158.5%
0.04%
+56.5%
Q1 2015$3,121,000
+0.1%
82,000
+2.5%
0.02%
+4.5%
Q4 2014$3,117,00080,0000.02%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders